The cerebrospinal fluid immunoglobulin transcriptome and proteome in neuromyelitis optica reveals central nervous system-specific B cell populations

[1]  S. Kusunoki,et al.  Efficacy of the anti–IL-6 receptor antibody tocilizumab in neuromyelitis optica , 2014, Neurology.

[2]  J. Bennett,et al.  The Treatment of Neuromyelitis Optica , 2014, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[3]  Su-Yoen Park,et al.  Factors Associated With the Time to Next Attack in Neuromyelitis Optica: Accelerated Failure Time Models With Random Effects , 2013, PloS one.

[4]  R. Gold,et al.  Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy. , 2013, JAMA neurology.

[5]  M. Papadopoulos,et al.  Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss , 2012, Acta Neuropathologica.

[6]  Bernhard Hemmer,et al.  Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies , 2011, Multiple sclerosis international.

[7]  R. Bergamaschi,et al.  Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures , 2011, Journal of the Neurological Sciences.

[8]  J. Kostić,et al.  Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders , 2011, Journal of Neuroimmunology.

[9]  D. Hafler,et al.  Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin , 2011, Journal of Neuroimmunology.

[10]  A. Verkman,et al.  Binding Affinity and Specificity of Neuromyelitis Optica Autoantibodies to Aquaporin-4 M1/M23 Isoforms and Orthogonal Arrays* , 2011, The Journal of Biological Chemistry.

[11]  B. Hemmer,et al.  Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica. , 2010, Archives of neurology.

[12]  F. Paul,et al.  Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance , 2010, Journal of Neuroinflammation.

[13]  B. Hemmer,et al.  Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica , 2009, Annals of neurology.

[14]  Y. Itoyama,et al.  Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo , 2009, Annals of neurology.

[15]  A. Vincent,et al.  Antibody to aquaporin-4 in the long-term course of neuromyelitis optica , 2008, Brain : a journal of neurology.

[16]  R. Hohlfeld,et al.  Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis , 2008, Nature Medicine.

[17]  B. Weinshenker,et al.  The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.

[18]  Y. Itoyama,et al.  Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. , 2007, Brain : a journal of neurology.

[19]  B. Weinshenker,et al.  Revised diagnostic criteria for neuromyelitis optica , 2006, Neurology.

[20]  A. Verkman,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .

[21]  R. Bergamaschi,et al.  Oligoclonal bands in Devic’s neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations , 2004, Multiple sclerosis.

[22]  D. Gilden,et al.  Single-Cell Repertoire Analysis Demonstrates that Clonal Expansion Is a Prominent Feature of the B Cell Response in Multiple Sclerosis Cerebrospinal Fluid 1 , 2003, The Journal of Immunology.

[23]  H. Reiber.  Cerebrospinal fluid - physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases , 1998, Multiple sclerosis.

[24]  H. Reiber,et al.  The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis , 1998, Multiple sclerosis.

[25]  J. Leavitt.  NMO-IgG detected in CSF in seronegative neuromyelitis optica , 2010 .